Genus Capital Management’s MetLife MET Stock Holding History

Genus Capital Management’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,674	Closed	-$221K	–	210
2024 Q3	$221K	Sell	2,674 -194	-7%	-$14.5K	0.03%	182
2024 Q2	$201K	Buy	+2,868	New	+$205K	0.03%	184
2024 Q1	–	Sell	-3,198	Closed	-$211K	–	319
2023 Q4	$211K	Buy	+3,198	New	+$200K	0.03%	183

Other funds holding MET

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Genus Capital Management's MET Position: Q2 2024 in Review

Genus Capital Management sold out of MetLife (MET) in Q2 2024, closing a stake of 3,198 shares — an estimated $228K sold.

Genus Capital Management first reported a position in MET in Q2 2023 and held it in 3 quarters. The position peaked at $237K in Q1 2024. 1,296 funds tracked by Wall St. Rank hold MET as of Q2 2024.

Genus Capital Management reported no remaining MetLife position as of Q2 2024 after selling out during the quarter.
Genus Capital Management sold 3,198 MetLife shares in Q2 2024, an estimated $228K.
Genus Capital Management first reported a position in MetLife in Q2 2023 and held it in 3 quarters.
Genus Capital Management's MetLife position peaked at $237K in Q1 2024.
1,296 funds tracked by Wall St. Rank held MetLife as of Q2 2024.

Based on Genus Capital Management's 13F filing for Q2 2024, filed 9 Aug 2024.